Durham’s BioCryst has high hopes for COVID-19 treatment trial which US is funding
Durham-based BioCryst Pharmaceuticals will conduct a clinical trial in Brazil to see if its investigational anti-viral drug is effective in treating the COVID-19 coronavirus.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
